Posted inNews and Updates
FDA Approves Regeneron’s Sohonos for Rare Bone Disorder
The FDA has approved Regeneron’s Sohonos to treat fibrodysplasia ossificans progressiva. Learn how this new therapy impacts the rare bone disease market.
Posted inNews and Updates
New Chemotherapy-Free Treatment for Metastatic Breast Cancer
A new study shows promise for treating metastatic breast cancer without chemotherapy, utilizing targeted therapies to improve patient quality of life.
Posted inNews and Updates
Bayer Unveils New Phase III Heart and Kidney Trial Data
Bayer will present pivotal Phase III trial data on heart, kidney, and stroke treatments at ESC 2026. Discover how these findings may shift clinical care.
Posted inNews and Updates
Personalized mRNA Vaccine Shows Promise Against Melanoma
New clinical results show a personalized mRNA vaccine significantly prevents melanoma recurrence by training the immune system to target cancer cells.
Posted inNews and Updates
New SRP-1005 Gene Therapy Trial Targets Huntington’s
The INSIGHTT trial has launched to test SRP-1005, a novel gene therapy aimed at lowering toxic huntingtin protein levels in Huntington’s disease patients.
Posted inNews and Updates
PleoPharma Secures $6.5M Grant for Cannabis Withdrawal Drug
PleoPharma receives a $6.5M NIDA grant to launch a Phase 3 trial for PP-01, a potential breakthrough treatment for Cannabis Use Disorder withdrawal symptoms.
Posted inNews and Updates
Mitochon Pharma Wins $1M ALS Grant for Phase II Trials
Mitochon Pharmaceuticals secures a $1M grant from the ALS Association to advance Phase II clinical trials for its neuroprotective drug candidate, BED-001.
Posted inNews and Updates
Novo Nordisk Tests Lower Dosing for Wegovy Oral Pill
Novo Nordisk has launched a clinical trial for lower-dose oral Wegovy, aiming to improve patient compliance and reduce side effects in weight management.
Posted inNews and Updates
Breakthrough Brain Implant Uses Infrared Light for Signals
Revolutionary new brain implants are now using infrared light to transmit neural signals, potentially transforming the future of medical neurotechnology.
Posted inNews and Updates
Joining a Clinical Trial: A Patient’s Guide to Eligibility
Thinking about joining a clinical trial? Explore the complex eligibility requirements, logistical barriers, and key considerations for potential patients.